ArticleJournal of gastrointestinal oncology2025
Clinical application of indocyanine green fluorescence imaging technology in laparoscopic rectal cancer surgery.
Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rectal cancer is one of the most widespread malignant tumors in the world, with the common treatment methods being surgery, chemotherapy, and radiotherapy. Due to its minimally invasive nature and associated rapid postoperative recovery, laparoscopic radical surgery has become one of the preferred options for treating rectal cancer. With the continuous advancement of surgical techniques and the integration of advanced technologies, especially the application of indocyanine green (ICG) fluorescence technology, the precision and efficiency of surgeries have been greatly improved, fundamentally changing the approach to complex operations. One of the most innovative advancements is the use of ICG fluorescence navigation, particularly in laparoscopic colorectal cancer surgery. This technology leverages the properties of ICG, a near-infrared fluorescent dye, to enhance the visualization of key anatomical structures during surgery. The application of ICG fluorescence technology in laparoscopic rectal cancer surgery is a significant breakthrough, providing surgeons with a novel approach for improving intraoperative decision-making. This study aimed to examine the clinical application of ICG fluorescence imaging technology in laparoscopic rectal cancer surgery. A patient with rectal cancer was selected, and ICG was injected before surgery. During the procedure, a laparoscopic fluorescence imaging system was used to observe fluorescence signals from the tumor and lymph node areas in real time. The fluorescence imaging results were compared with those of conventional imaging to assess the role of this technology in tumor resection and lymph node dissection. Postoperative pathological examination was conducted to verify the accuracy of the imaging results, and postoperative follow-up was carried out to further determine the clinical value of ICG fluorescence imaging in rectal cancer surgery. In addition, we developed a case report guide containing 13 components: title, keywords, abstract, introduction, patient information, clinical findings, timeline, diagnostic evaluation, treatment intervention, follow-up, results, discussion, patient perspectives, and informed consent. Considering our findings, we believe that ICG fluorescence navigation technology will play an increasingly important role in the surgical treatment of rectal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.